Mucosal and submucosal lesions of the digestive tract
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age >=18 years old, gender-neutral; 2.endoscopically confirmed rectal lesions that meet the indications for ESD; 3.endoscopically confirmed esophageal and gastric mucosal lesions that meet the indications for ESD; 4.submucosal tumors of the gastrointestinal tract that meet the indications for endoscopic treatment of SMT; 5.tolerance of general anesthesia anesthesia; 6.inclusion in the study was informed of the study and signed an informed consent form.
Exclusion criteria
Exclusion criteria: 1.Menstruating, pregnant, breastfeeding women; 2.history of previous gastric and colorectal surgery; 3.people with serious organic diseases such as cardiovascular, cerebrovascular, pulmonary, hepatic, renal; 4.people with hematologic diseases and coagulation disorders; 5.people with inflammatory bowel disease; 6.people with history of anticoagulant medication taken within one week before the operation; 7.people who are enrolled in other clinical trials within four weeks. 8.Contraindications for endoscopic resection of SMT: (1). For lesions with definite lymph node or distant metastasis. (2)For some SMT with definite lymph node or distant metastasis, large biopsy is required to obtain pathology, which can be regarded as a relative contraindication.;(3)After detailed preoperative evaluation, it is determined that the general condition is poor and cannot tolerate endoscopic surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Operative time;Complication rate ;Complete resection rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Hospitalization days;WBC;Usage of traction methods;pathology; | — |
Countries
China
Contacts
Department of Gastroenterology, The Fourth Affiliated Hospital of China Medical University